CD4 and inflammatory bowel disease: In IBD, pro-inflammatory cytokines, like TNF-α, IL-23, and IL-6, enhance miR-301a expression in CD4+ T cells, which in turn facilitate Th17 cell differentiation and TNF-α production by inhibiting SNIP1.